Back Pain News and Research

Latest Back Pain News and Research

Boniva generics receive FDA approval for treatment, prevention of osteoporosis

Boniva generics receive FDA approval for treatment, prevention of osteoporosis

CSL Behring commences enrollment in SCIg PATH trial for CIDP

CSL Behring commences enrollment in SCIg PATH trial for CIDP

Minimally invasive treatments could target ‘hunger hormone’

Minimally invasive treatments could target ‘hunger hormone’

Two SpinalMotion's sub-5mm Kineflex|C cervical total disc replacements receive CE Mark

Two SpinalMotion's sub-5mm Kineflex|C cervical total disc replacements receive CE Mark

NEJM publishes results from Teva's laquinimod Phase III study on RRMS

NEJM publishes results from Teva's laquinimod Phase III study on RRMS

Back pain and school children's backpacks

Back pain and school children's backpacks

Researchers discover molecular mechanism responsible for low back pain

Researchers discover molecular mechanism responsible for low back pain

The two sides of pain

The two sides of pain

FDA panel favors continued research on novel pain medicine

FDA panel favors continued research on novel pain medicine

Yoga may be effective in treating patients with stress-related psychological and medical conditions

Yoga may be effective in treating patients with stress-related psychological and medical conditions

Lixiu, BIEL announce distribution agreement for RecoveryRx devices

Lixiu, BIEL announce distribution agreement for RecoveryRx devices

Volunteers wanted for chronic pain research

Volunteers wanted for chronic pain research

Treatment with vitamin D reduces size of uterine fibroids

Treatment with vitamin D reduces size of uterine fibroids

RMC offers groundbreaking new procedure for LSS patients

RMC offers groundbreaking new procedure for LSS patients

New approaches may increase effectiveness of SCS for severe back pain

New approaches may increase effectiveness of SCS for severe back pain

Chronic pain patients at high-risk for comorbid substance abuse benefit from 3-week program

Chronic pain patients at high-risk for comorbid substance abuse benefit from 3-week program

AstraZeneca launches ARIMIDEX Direct to help cancer patients

AstraZeneca launches ARIMIDEX Direct to help cancer patients

Acorda's fourth quarter GAAP net income increases to $12.7 million

Acorda's fourth quarter GAAP net income increases to $12.7 million

Kowa announces data of LIVALO vs. Crestor on pharmacodynamics of warfarin

Kowa announces data of LIVALO vs. Crestor on pharmacodynamics of warfarin

Children with multiple psychosomatic symptoms more likely to experience physical abuse

Children with multiple psychosomatic symptoms more likely to experience physical abuse

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.